192 related articles for article (PubMed ID: 12195125)
21. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan.
Shetty SS; DelGrande D
J Pharmacol Exp Ther; 2000 Jul; 294(1):179-86. PubMed ID: 10871310
[TBL] [Abstract][Full Text] [Related]
22. Different prejunctional and postjunctional responses to angiotensin II and AT1-receptor inhibition: influence of maturation.
Nap A; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2004 Mar; 43(3):432-9. PubMed ID: 15076228
[TBL] [Abstract][Full Text] [Related]
23. Interactions between the renin-angiotensin system (RAS) and the sympathetic system.
Dendorfer A; Raasch W; Tempel K; Dominiak P
Basic Res Cardiol; 1998; 93 Suppl 2():24-9. PubMed ID: 9833158
[TBL] [Abstract][Full Text] [Related]
24. Vasopressin-induced presynaptic facilitation of sympathetic neurotransmission in the pithed rat.
Streefkerk JO; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens; 2002 Jun; 20(6):1175-80. PubMed ID: 12023688
[TBL] [Abstract][Full Text] [Related]
25. Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2002 Jul; 40(1):50-7. PubMed ID: 12072577
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of KT3-671, a non-peptide angiotensin subtype 1 receptor antagonist, on sympathetic neurotransmission in isolated rabbit aorta.
Takata Y; Tajima S; Kato H
Pharmacol Res; 2000 Mar; 41(3):335-40. PubMed ID: 10675286
[TBL] [Abstract][Full Text] [Related]
27. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
[TBL] [Abstract][Full Text] [Related]
28. In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan.
Fabiani ME; Dinh DT; Nassis L; Casley DJ; Johnston CI
Am J Hypertens; 2000 Sep; 13(9):1005-13. PubMed ID: 10981551
[TBL] [Abstract][Full Text] [Related]
29. Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat.
Cox SL; Story DF; Ziogas J
Br J Pharmacol; 1996 Nov; 119(5):976-84. PubMed ID: 8922748
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.
Schupp M; Janke J; Clasen R; Unger T; Kintscher U
Circulation; 2004 May; 109(17):2054-7. PubMed ID: 15117841
[TBL] [Abstract][Full Text] [Related]
31. Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors.
Vanderheyden PM; Fierens FL; De Backer JP; Fraeyman N; Vauquelin G
Br J Pharmacol; 1999 Feb; 126(4):1057-65. PubMed ID: 10193788
[TBL] [Abstract][Full Text] [Related]
32. AT1-receptor antagonists abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis.
Wolf G; Schneider A; Helmchen U; Stahl RA
Exp Nephrol; 1998; 6(2):112-20. PubMed ID: 9567217
[TBL] [Abstract][Full Text] [Related]
33. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the AT1 angiotensin II receptor expressed in guinea pig liver.
García-Sáinz JA; Martínez-Alfaro M; Romero-Avila MT; González-Espinosa C
J Endocrinol; 1997 Jul; 154(1):133-8. PubMed ID: 9246947
[TBL] [Abstract][Full Text] [Related]
35. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
Fierens FL; Vanderheyden PM; De Backer JP; Vauquelin G
Eur J Pharmacol; 1999 May; 372(2):199-206. PubMed ID: 10395100
[TBL] [Abstract][Full Text] [Related]
36. Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites.
Cox SL; Ben A; Story DF; Ziogas J
Br J Pharmacol; 1995 Mar; 114(5):1057-63. PubMed ID: 7780640
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner HR; Burnier M
Hypertension; 1999 Mar; 33(3):850-5. PubMed ID: 10082498
[TBL] [Abstract][Full Text] [Related]
38. Reduction of vascular noradrenaline sensitivity by AT1 antagonists depends on functional sympathetic innervation.
Raasch W; Dominiak P; Ziegler A; Dendorfer A
Hypertension; 2004 Sep; 44(3):346-51. PubMed ID: 15262904
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors.
Goldenberg I; Grossman E; Jacobson KA; Shneyvays V; Shainberg A
J Hypertens; 2001 Sep; 19(9):1681-9. PubMed ID: 11564990
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
